Jun
30
Filed Under (Main Content) by Content Keyword RSS
The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on.
Teva Pharmaceutical Industries Ltd. is testing a copy of Roche Holding AGs second-biggest-selling drug Rituxan in what may be the first U.S. generic version of a monoclonal antibody, a protein-based medicine used to treat diseases ranging from arthritis to cancer.
May 25 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. is testing a copy of Roche Holding AG s second-biggest-selling drug Rituxan in what may be the first generic version of a monoclonal antibody, a protein-based medicine used to treat diseases ranging from arthritis to cancer.
May 25 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. is testing a copy of Roche Holding AG s second-biggest-selling drug Rituxan in what may be the first generic version of a monoclonal antibody, a protein-based medicine used to treat diseases ranging from arthritis to cancer.
May
21
The burden of arthritis is greater for African Americans and Hispanics, despite lower prevalence among these groups according to a Centers for Disease Control and Prevention (CDC) report published in the May issue of Preventing Chronic Disease.